JMP Securities Reiterates Market Outperform on US Physical Therapy, Maintains $113 Price Target
Benzinga Newsdesk 1 year ago
NewsPrice TargetReiterationAnalyst Ratings
JMP Securities analyst Constantine Davides reiterates US Physical Therapy (NYSE:USPH) with a Market Outperform and maintains $113 price target.
JMP Securities analyst Constantine Davides reiterates US Physical Therapy (NYSE:USPH) with a Market Outperform and maintains $113 price target.